GlaxoSmithKline plc – Annual report – 31 December 2023
Industry: pharmaceuticals
43. Reconciliation of net cash flow to movement in net debt
For further information on significant changes in net debt see Note 30, ‘Net debt’.
IAS 7 paras 44A-44E, changes in liabilities arising from financing activities
Accounts examples 